Omixon’s Breakfast Seminar at ASBMT

Come and join  Omixon for a breakfast seminar at to learn about the benefits of using next generation sequencing  for transplantation genetics. You will learn how to reduce ambiguity, increase resolution of HLA typing at an affordable price point. The presentation will also address the challenges current early adopters face...

 

Read more

The Long Indel Contest

In order to raise awareness of biological importance of insertions and deletions as genomic variants, we have introduced a scientific challenge: The Long Indel Contest. The goal is to find long insertions and deletions up to 1024 base pairs in length, based on human Next Generation Sequencing (NGS) data and reference...

 

Read more

Omixon will be attending American Society of Bone and Marrow Transplantation Salt Lake City, 13-17 February 2013

The American Society for Blood and Marrow Transplantation is an international professional association that promotes the advancement of the blood and marrow transplantation field.  ASBMT members are both in clinical practice, in research, and health professionals. From its beginning, ASBMT activities have been representing the interests of transplant clinicians and...

 

Read more

Omixon could be “The Most Promising Company” of 2013

Omixon is presenting and exhibiting  at the upcoming Personalized Medicine World Conference in Mountain View, from 28-29th Jan 2013. We are a nominee for the “The Most Promising Company” award.  Emerging companies that develop solutions for the next generation of personalized medicine platforms are invited to the competition.

 

Read more